Seizing upon a favorable business climate in Europe, US businesswoman Lisa Drakeman has blended goal-oriented American culture with a European focus on team effort to move her firm's antibodies closer to the market.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout
Author information
Authors and Affiliations
Related links
Rights and permissions
About this article
Cite this article
DeFrancesco, L. Profile: Lisa Drakeman. Nat Biotechnol 23, 1035 (2005). https://doi.org/10.1038/nbt0905-1035
Published:
Issue date:
DOI: https://doi.org/10.1038/nbt0905-1035
